Under Carolin's stewardship MiroBio managed to raise as $97 million series B financing round. The round was led by Medicxi with participation from an impressive line-up of new investors, OrbiMed and Monograph and existing Series A investors, Oxford Science Enterprises, Samsara BioCapital, SR One and Advent Life Sciences. In August ’22, only a few months after raising its Series B capital, MiroBio was sold to Gilead for $405 mio.

Raising money needs more than a story - what's your investment case?

You need to present a compelling story but your story needs to be built around and supported by your investment case. Part of your investment case is answering why should I put money into your venture versus others, what value can you build for your investors and how, what are possible exit strategies and when might your investors see what level of returns.